Probiotics, prebiotics, and postbiotics in burn wound healing: Antimicrobial, anti-inflammatory, and immunomodulatory perspectives
4 affiliations
- 1Faculty of Life Science Engineering, College of Interdisciplinary Science and Technologies, University of Tehran, Tehran, Iran
- 2Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
- 3Department of Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
- 4Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran
Abstract
Burn injuries remain a major clinical challenge because of delayed wound healing, infection risk, and sustained inflammatory stress. Conventional therapies, including topical antimicrobials and systemic antibiotics, are limited by impaired tissue repair, microbial resistance, and dysbiosis. This mini-review aimed to summarize the current evidence on the potential roles and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics in burn wound healing, with particular emphasis on their antimicrobial, anti-inflammatory, immunomodulatory, and regenerative effects, as well as emerging delivery strategies. A comprehensive literature search was conducted to identify and synthesize available evidence on microbiome-targeted interventions in burn wound management, including mechanistic, experimental, and clinical studies, with consideration of their therapeutic effects, safety, and delivery systems. Probiotics and prebiotics have emerged as promising adjunctive approaches in burn care through antimicrobial, anti-inflammatory, and immunomodulatory mechanisms. Probiotics may suppress pathogen colonization, inhibit biofilm formation, and modulate cytokine responses, whereas prebiotics support beneficial microbiota and the production of bioactive metabolites such as short-chain fatty acids. In addition, postbiotics and delivery platforms such as hydrogels and encapsulated formulations may improve local stability, safety, and therapeutic efficacy. Available evidence suggests that selected microbiome-targeted interventions may reduce infectious complications and influence inflammatory and immune responses in burn patients, but clinical evidence remains limited and heterogeneous. Differences in strains, formulations, routes, treatment duration, and clinical outcomes, together with the predominance of preclinical evidence for several approaches, limit definitive conclusions regarding efficacy. Larger, standardized burn-specific clinical trials are needed to establish optimal interventions and safety.
Related
- Molecular mechanisms involved in the anticancer activities of probiotics and postbiotics.
- Immunomodulatory Probiotics in Psoriasis: Effects on the Gut–Skin–Immune Crosstalk and Systemic Inflammation
- Euonymus alatus-Derived Extracellular Vesicles Show Immunomodulatory Effects in an Inflammatory Thyroid Follicular Cell Model: Insights from Multi-Omics Analysis
- Probiotics and Semaglutide Therapy: Mechanistic Perspectives and Potential Interactions in Gut Microbiota, Gastrointestinal Function, and Metabolic Health
- Microbiome-Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics.
BibTeX
@article{semnany2026probiotics,
title = {{Probiotics, prebiotics, and postbiotics in burn wound healing: Antimicrobial, anti-inflammatory, and immunomodulatory perspectives}},
author = {Nooshin Semnany and Fatemeh EmamiPari and Alireza Gohari and Mahsa Sadeghi and Meysam Hasannejad-Bibalan},
journal = {Iranian Journal of Burns and Wound Research},
year = {2026},
month = sep,
doi = {10.66224/ijbwr.2.3.76},
url = {https://doi.org/10.66224/ijbwr.2.3.76},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Probiotics, prebiotics, and postbiotics in burn wound healing: Antimicrobial, anti-inflammatory, and immunomodulatory perspectives
AU - Nooshin Semnany
AU - Fatemeh EmamiPari
AU - Alireza Gohari
AU - Mahsa Sadeghi
AU - Meysam Hasannejad-Bibalan
PY - 2026
DA - 2026/09/01
JO - Iranian Journal of Burns and Wound Research
DO - 10.66224/ijbwr.2.3.76
UR - https://doi.org/10.66224/ijbwr.2.3.76
AB - Burn injuries remain a major clinical challenge because of delayed wound healing, infection risk, and sustained inflammatory stress. Conventional therapies, including topical antimicrobials and systemic antibiotics, are limited by impaired tissue repair, microbial resistance, and dysbiosis. This mini-review aimed to summarize the current evidence on the potential roles and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics in burn wound healing, with particular emphasis on their antimicrobial, anti-inflammatory, immunomodulatory, and regenerative effects, as well as emerging delivery strategies. A comprehensive literature search was conducted to identify and synthesize available evidence on microbiome-targeted interventions in burn wound management, including mechanistic, experimental, and clinical studies, with consideration of their therapeutic effects, safety, and delivery systems. Probiotics and prebiotics have emerged as promising adjunctive approaches in burn care through antimicrobial, anti-inflammatory, and immunomodulatory mechanisms. Probiotics may suppress pathogen colonization, inhibit biofilm formation, and modulate cytokine responses, whereas prebiotics support beneficial microbiota and the production of bioactive metabolites such as short-chain fatty acids. In addition, postbiotics and delivery platforms such as hydrogels and encapsulated formulations may improve local stability, safety, and therapeutic efficacy. Available evidence suggests that selected microbiome-targeted interventions may reduce infectious complications and influence inflammatory and immune responses in burn patients, but clinical evidence remains limited and heterogeneous. Differences in strains, formulations, routes, treatment duration, and clinical outcomes, together with the predominance of preclinical evidence for several approaches, limit definitive conclusions regarding efficacy. Larger, standardized burn-specific clinical trials are needed to establish optimal interventions and safety.
SN - 3060-8414
ER -